Systemic exposure to fluticasone MDI delivered through antistatic chambers.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 21783234.
- Also identified by DOI 10.1016/j.jaci.2011.06.014 and PMC identifier 3811012.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We performed this study to evaluate how age and device affect the systemic exposure of inhaled fluticasone propionate (FP) in children. The findings indicate an anti-static valved holding chamber significantly increases systemic exposure of FP.
Medical subject headings
- Androstadienes
- Anti-Asthmatic Agents
- Inhalation Spacers